ADHD and addiction are closely connected, and the connection runs deeper than most people realise. Adults with ADHD are significantly more likely to develop a substance use disorder than those without it, and approximately one in five people seeking addiction treatment also has ADHD. The link involves shared neurobiology, particularly in dopaminergic pathways, as well as impulsivity, self-medication patterns, and a greater vulnerability to reward-seeking behaviour. This guide explains why the two conditions so often co-occur, what that means for treatment, and why addressing both together produces better outcomes than treating either one alone.
Why ADHD and Addiction So Often Occur Together
The overlap between ADHD and substance use disorder is not coincidental. Research consistently shows that adults with ADHD are approximately two to three times more likely to develop a substance use disorder than adults without the condition, according to a systematic review published in PMC. The specific risk varies by substance: the elevated risk is higher for nicotine and cocaine, and somewhat lower but still significant for alcohol and cannabis.
The numbers run in both directions. CHADD (Children and Adults with ADHD) reports that approximately one in four adults seeking treatment for a substance use disorder also meets criteria for ADHD. In addiction treatment settings, ADHD is far more common than in the general population, where it affects roughly two to three percent of adults.
Yet in the vast majority of cases where both conditions are present, ADHD is not identified or treated. Most addiction treatment programmes do not routinely screen for it. The result is a significant gap: a person works hard to address their substance use, but the neurological driver underlying it remains unrecognised.
The Dopamine Connection: Shared Neurobiology
To understand why ADHD and addiction co-occur so frequently, it helps to understand what both conditions have in common at a neurobiological level.
In ADHD, dysfunction in the brain’s dopaminergic system is thought to contribute to the core difficulties with attention, motivation, and impulse control. Dopamine plays a central role in the brain’s reward and motivation circuits, and evidence suggests that impaired dopamine signalling in the prefrontal and striatal regions may contribute to the characteristic difficulty with sustaining focus, regulating impulses, and tolerating delayed gratification. This is an area of active research, and the full picture is more complex than a simple “dopamine deficiency” — but the reward-processing difficulties associated with ADHD are well-established.
Addiction involves the same reward circuitry. Substances of abuse act on dopamine pathways, producing rapid increases in dopamine activity that the brain eventually adapts to. Over time, the person with addiction requires the substance to feel any sense of reward or normality. This pattern is accelerated in people whose dopamine system was already dysregulated before substance use began.
The practical consequence is that both conditions are fundamentally driven by the same kind of reward-processing difficulty, expressed differently. ADHD makes it harder to sustain effort for delayed rewards; addiction arises when a very fast, very intense reward mechanism takes over. Both are neurological, not character failures.
Self-Medication: Using Substances to Manage ADHD Symptoms
One pattern that emerges frequently in clinical practice is the self-medication hypothesis: the idea that some people with ADHD turn to substances specifically because those substances temporarily reduce the distress of living with unmanaged ADHD symptoms.
Evidence suggests this is a real and recognisable pattern. Cocaine, which is itself a stimulant, may paradoxically increase focus in some individuals with ADHD by activating the same dopaminergic pathways that ADHD medication targets. Cannabis may reduce the hyperactivity and inner restlessness that ADHD produces. Alcohol may dampen the overactive thought processes and anxiety that often accompany the condition. None of these effects last, and all of them worsen the underlying neurological difficulties over time, but in the short term they can feel like relief.
This does not mean that everyone with ADHD who uses substances is consciously self-medicating. Often the connection is not recognised until someone reflects back on why a particular substance felt so appealing or functional at first. What it does mean is that the use is not random. For many people, it follows the shape of their unmet neurological needs.
Understanding this pattern matters because it changes how treatment should be approached. If the substance was meeting a need, the treatment needs to address that need — not just remove the substance.
How ADHD Makes Addiction Harder to Overcome
When ADHD and substance use disorder occur together, the clinical picture is more challenging than either condition alone. Research consistently finds that people with both diagnoses tend to start using substances at a younger age, progress to dependence more quickly, and experience higher rates of relapse than those with addiction alone.
There is also a well-documented difficulty with treatment adherence. ADHD-related executive function deficits — the difficulties with planning, organising, managing time, and regulating impulsive behaviour — can make it genuinely harder to keep appointments, follow structured programmes, and sustain effort through the slower stages of recovery when results are not immediately visible. This is not lack of motivation. It is a predictable consequence of the same brain differences that drive the addiction in the first place.
According to clinical researchers reviewing ADHD-SUD treatment challenges, the combination is also associated with higher rates of polysubstance use, more hospitalisations, and more severe presentations than SUD alone. None of this is hopeless — but it does mean that standard addiction treatment, designed without ADHD in mind, will often fall short if the ADHD is not part of the treatment plan.
The Question of Stimulant Medication
One of the most common concerns for people with ADHD who also struggle with addiction is the question of stimulant medication: will taking medication for ADHD make addiction worse? This concern is understandable, and it comes up regularly, but the current evidence does not support it.
CHADD’s clinical guidance and peer-reviewed research to date have found no evidence that properly prescribed stimulant medications increase the risk of substance use disorder in people with ADHD. In dual-diagnosis settings, long-acting formulations are preferred over short-acting ones, as they produce more stable blood levels with less peak-and-trough variation and lower misuse potential.
For individuals in recovery who are concerned about stimulant use, non-stimulant options — such as atomoxetine — are also available and may be more appropriate depending on the individual’s history and the nature of their addiction.
The critical point is this: these decisions must be made by a qualified psychiatrist or prescriber who can assess the full clinical picture. Never stop, start, or adjust ADHD medication independently, particularly during active recovery. Medication management in dual-diagnosis care is a clinical process, not a self-guided one.
Why Treating Addiction Alone Is Often Not Enough
Many people with undiagnosed ADHD have attempted addiction treatment before. They put in the work, completed programmes, stayed engaged in the early weeks, and then relapsed. Often, they blame themselves.
What is frequently missed is that when ADHD goes unidentified, the neurological conditions that drove the substance use in the first place remain fully active after the substance is removed. The impulsivity does not reduce. The difficulty tolerating discomfort does not reduce. The pull towards immediate stimulation does not reduce. Without addressing these, the probability of relapse remains high regardless of the quality of the addiction treatment.
The international consensus statement on screening, diagnosis and treatment of SUD patients with comorbid ADHD, published in the journal European Addiction Research, is direct on this: integrated simultaneous treatment of both ADHD and SUD, using a combination of pharmacotherapy and psychotherapy, is recommended. Treating one while deferring the other produces worse outcomes.
The implication for people who have found that addiction treatment alone has not held is clear: if ADHD has not been assessed, it is worth asking whether that gap is part of the picture.
What Integrated ADHD and Addiction Treatment Involves
Effective dual-diagnosis treatment for ADHD and addiction is not simply two separate treatments running side by side. It is a genuinely integrated approach in which both conditions are understood in relation to each other.
A thorough assessment is the starting point, including a formal ADHD evaluation by a psychiatrist experienced in both ADHD and addiction. This is important because some ADHD symptoms overlap with the effects of substance use or withdrawal, and accurate diagnosis requires clinical skill.
The psychotherapy component typically includes Cognitive Behavioural Therapy adapted for the ADHD-SUD presentation, addressing impulsivity, emotional dysregulation, planning difficulties, and the thought patterns that sustain both conditions. Peer-reviewed clinical research suggests that combined pharmacological and psychotherapeutic treatment produces better outcomes than either approach alone.
Daily structure is particularly valuable for people with ADHD. The executive function deficits that ADHD involves, particularly in planning and sustaining routines, mean that an unstructured recovery environment creates additional risk. A residential programme with a clear daily timetable, therapeutic activities, and consistent human support addresses this directly.
Psychiatric oversight for medication management, group therapy with dual-diagnosis peers, and a well-designed aftercare programme complete the picture. The aftercare component is especially important given the higher relapse risk associated with ADHD.
Dual-Diagnosis Treatment at The Orchid Recovery, Chiang Mai
The Orchid Recovery is a boutique residential addiction and mental health treatment programme in the Hang Dong District of Chiang Mai, Thailand, providing personalised care for a maximum of 20 international clients at any one time.
Psychiatric assessment is led by Dr. Suttipan Takkapaijit, our CEO and full-time on-site psychiatrist (MD, Thai medical licence 13333). Dr. Suttipan’s full-time presence means that dual-diagnosis assessment, including ADHD evaluation and medication review, is available throughout the residential stay and not limited to a single intake appointment. For clients who arrive with a known ADHD diagnosis, the existing treatment picture can be reviewed and integrated into the programme from the outset.
Our residential treatment programme in Thailand incorporates both evidence-based therapies and a structured holistic timetable. CBT and DBT are delivered individually and in group formats, alongside psychiatric review and regular one-to-one sessions. For people whose ADHD has historically made it difficult to sustain recovery in less structured environments, the immersive 24-hour residential setting removes many of the practical obstacles that outpatient care leaves in place.
Mood disorder treatment is integrated into our clinical pathway, recognising that ADHD frequently co-occurs not only with addiction but also with depression, anxiety, and emotional dysregulation. Our anxiety treatment programme addresses the anxiety that commonly accompanies ADHD, and is delivered alongside the addiction work rather than separately.
The holistic elements of the programme — yoga, Thai massage, meditation, and Muay Thai — are not incidental. For people with ADHD, regular physical activity and mindfulness-based practices have particular relevance for dopaminergic regulation and emotional management. You can read more about how we use holistic treatment at Orchid as part of the clinical design.
If you are curious about how EMDR fits with ADHD specifically, our existing article on EMDR and ADHD covers this in more detail.
Programmes run across 4, 8, and 12-week residential stays, each followed by two months of complimentary aftercare. The aftercare provision is particularly relevant for people with ADHD, for whom the transition out of a structured residential environment is a recognised high-risk period.
Not sure where to start? Talk to us about dual-diagnosis assessment If you recognise a pattern of ADHD and addiction in your own life — or someone close to you — our admissions team is here to listen. We can explain how dual-diagnosis treatment works at Orchid, answer your questions about what the programme involves, and help you understand whether residential treatment is the right next step. No pressure, no commitment. Speak to our team: /contact-us/
Sources
- van Emmerik-van Oortmerssen et al. “Often Overlooked and Ignored, but Do Not Underestimate Its Relevance: ADHD in Addiction.” PMC7949230 (2021). https://pmc.ncbi.nlm.nih.gov/articles/PMC7949230/
- CHADD (Children and Adults with ADHD). “When ADHD and Substance Use Disorders Coexist.” https://chadd.org/attention-article/when-adhd-and-substance-use-disorders-coexist/
- Morin et al. “Challenges of Treating ADHD with Comorbid Substance Use Disorder.” PMC10179386 (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC10179386/
- Crunelle et al. “International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid ADHD.” European Addiction Research, PMC5986068 (2018). https://pmc.ncbi.nlm.nih.gov/articles/PMC5986068/
- NHS Scotland. “ADHD Guidelines Update June 2024.” https://www.rightdecisions.scot.nhs.uk/m/2xtjn15q/adhd-guidelines-update-approved-june-2024.pdf
Frequently Asked Questions
Can ADHD cause addiction?
ADHD does not directly cause addiction, but it is a significant risk factor. Adults with ADHD are approximately two to three times more likely to develop a substance use disorder than adults without the condition, according to research combining findings from 27 studies. The elevated risk is associated with impulsivity, reward-seeking behaviour, dopaminergic dysregulation, and the self-medication patterns that unmanaged ADHD can produce.
Why are people with ADHD more likely to use drugs or alcohol?
Several factors are involved. The impulsivity associated with ADHD makes it harder to resist immediate rewards, including substances. The difficulty tolerating boredom, restlessness, or emotional discomfort that ADHD produces can make substances feel genuinely relieving. And the dopaminergic pathways that function differently in ADHD are the same ones that substances act on, which may explain why some people with ADHD find that certain substances feel normalising rather than intoxicating.
Is it safe to take ADHD medication if you have an addiction?
The evidence to date does not support the common concern that properly prescribed ADHD medication increases addiction risk. In dual-diagnosis care, long-acting formulations of stimulant medication are generally preferred, as they carry lower misuse potential. Non-stimulant alternatives are also available for those with concerns about stimulant use in recovery. Any medication decision must be made by a qualified psychiatrist or prescriber who knows your full clinical history — never adjust ADHD medication independently during recovery.
Can addiction treatment work if ADHD is not treated?
When ADHD is undiagnosed and untreated, addiction treatment is working against an active neurological driver. The impulsivity, difficulty with planning, and pull towards immediate stimulation that ADHD produces remain fully present after the substance is removed. International clinical consensus recommends integrated simultaneous treatment of both conditions rather than treating them sequentially. People who have relapsed after previous addiction treatment may benefit from a formal ADHD assessment to see whether an unaddressed dual diagnosis is part of the picture.
What is dual diagnosis?
Dual diagnosis refers to the co-occurrence of a substance use disorder and a mental health condition — in this case, ADHD — in the same person at the same time. Dual-diagnosis treatment acknowledges that both conditions need to be assessed, understood in relation to each other, and treated in an integrated way. Treating only one while ignoring the other tends to produce incomplete results.
How is ADHD diagnosed in someone with addiction?
ADHD can be assessed even in the context of active addiction or early recovery, though clinical skill is required because some ADHD symptoms overlap with the effects of substance use or withdrawal. A qualified psychiatrist experienced in both adult ADHD and addiction will take a detailed developmental and clinical history, use validated screening tools, and consider the full clinical picture before reaching a diagnosis. Assessment is typically most reliable once acute intoxication or withdrawal has resolved.
What kind of therapy helps people with both ADHD and addiction?
Cognitive Behavioural Therapy adapted for the ADHD-SUD presentation is one of the most evidence-supported options. It addresses the impulsivity, emotional dysregulation, and planning difficulties that ADHD produces, alongside the patterns of thought and behaviour that maintain substance use. Motivational interviewing is also used to support engagement in recovery. The combination of psychological therapy, psychiatric medication review, structured daily routines, and aftercare produces better outcomes than any single element in isolation.
